BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6807704)

  • 1. Therapeutic modulation of bronchial hyperreactivity.
    Lowhagen O
    Eur J Respir Dis Suppl; 1982; 117():97-120. PubMed ID: 6807704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway hyperreactivity. Clinical treatment with drugs.
    Svedmyr N
    Eur J Respir Dis Suppl; 1983; 131():313-29. PubMed ID: 6141065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological rehabilitation of the asthmatic child.
    Debelić M
    Allergol Immunopathol (Madr); 1981; Suppl 9():99-102. PubMed ID: 6819777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ketotifen, nedocromil sodium and budesonide on non-specific bronchial hyperreactivity to histamine in patients with asthma].
    Siergiejko Z; Rutkowski R; Rogalewska A; Kazberuk M
    Pneumonol Alergol Pol; 1992; 60(11-12):37-42. PubMed ID: 1338947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An experimental and clinical study of the effect of ketotifen in the treatment of extrinsic bronchial asthma (author's transl)].
    Hartmann V; Magnussen H; Holle JP
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():309-11. PubMed ID: 37493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rational asthma drug therapy].
    Fischer JF; Meister W; Mohorn M
    Z Arztl Fortbild (Jena); 1983; 77(7):283-90. PubMed ID: 6407218
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the anti-allergic and anti-asthmatic effects of SM 857 (Doqualast) and DNCG].
    Wiessmann KJ; Ollrogge M; Rinast E
    Prax Klin Pneumol; 1987 Feb; 41(2):45-8. PubMed ID: 3106950
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical studies on the protective effects of Ketotifen and Intal in atopic asthmatic patients.
    Románski B; Pawlik-Miskiewicz K; Wilewska-Klubo T
    Allergol Immunopathol (Madr); 1983; 11(1):34-9. PubMed ID: 6407291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ketotifen (Zaditen) and disodium cromoglycinic acid (Intal) in the therapy of bronchial asthma].
    Nowak D; Magnussen H
    Prax Klin Pneumol; 1987 Sep; 41(9):319-23. PubMed ID: 3124092
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis of asthma with ketotifen in children and adolescents: a review.
    Craps L
    Pharmatherapeutica; 1983; 3(5):314-26. PubMed ID: 6405397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ketotifen in the prevention of bronchial asthma. International therapeutic evaluation].
    Craps L
    Allergol Immunopathol (Madr); 1981; Suppl 9():177-90. PubMed ID: 6131598
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
    Hegardt B; Arner B
    Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of inhaled heparin on post-leukotriene bronchoconstriction in children with bronchial asthma].
    Stelmach I; Jerzyńska J; Bobrowska M; Brzozowska A; Majak P; Kuna P
    Pol Merkur Lekarski; 2002 Feb; 12(68):95-8. PubMed ID: 11995261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial challenge as an experimental model for evaluating anti-allergic drugs.
    Löwhagen O; Lindholm N
    Scand J Respir Dis Suppl; 1977; 101():43-7. PubMed ID: 343239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ketotifen (Zaditen and K-Asthmal): a drug with sales disproportionate to its demonstrated effectiveness].
    Pérez-Padilla JR
    Gac Med Mex; 1999; 135(2):165-70. PubMed ID: 10327750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.
    Hegardt B; Pauwels R; Van Der Straeten M
    Allergy; 1981 Feb; 36(2):115-22. PubMed ID: 6112931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug prevention of allergic bronchial asthma. Comparison of the protective effects of ketotifen and cromoglycic acid].
    Herjavecz I; Böszörmény-Nagy G
    ZFA (Stuttgart); 1982 Sep; 58(26):1425-8. PubMed ID: 6817533
    [No Abstract]   [Full Text] [Related]  

  • 18. Ketotifen in the oral prophylaxis of bronchial asthma: a review.
    Craps L
    Pharmatherapeutica; 1981; 3(1):18-35. PubMed ID: 6119703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of asthma in adults: the control of bronchial inflammation.
    Olivieri D; Chetta A
    Eur Respir J Suppl; 1989 Jun; 6():540s-544s. PubMed ID: 2508647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term therapy of bronchial asthma with ketotifen. European experiences].
    Magnussen H
    Schweiz Med Wochenschr; 1980 Feb; 110(6):191-5. PubMed ID: 6103579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.